Advertisement
Screener

MAZE THERAPEUTICS, INC. (MAZE) Stock Splits

Available history
No dated observations
Data captured

Stock Splits coverage

Maze Therapeutics, Inc. (MAZE). What the retained company guidance contains and how many periods can be scored.

  • Retained split events: Value None reported.
  • Retained history: Value Retained daily history from 2025-01-31 through 2026-06-30.
  • Interpretation: Value The retained history is complete over that window and contains no such event; this is a completed zero, not missing normalization..
MeasureValue
Retained split eventsNone reported
Retained historyRetained daily history from 2025-01-31 through 2026-06-30
InterpretationThe retained history is complete over that window and contains no such event; this is a completed zero, not missing normalization.

Similar stocks

Stock NameCountryMarket CapPE Ratio
Inhibrx Biosciences, Inc. (INBX)United States$1.477B-10.08
Taysha Gene Therapies, Inc. (TSHA)United States$1.564B-14.80
Immunocore Holdings plc (IMCR)$1.613B-90.43
Hemab Therapeutics Holdings, Inc. (COAG)United States$1.672B
Replimune Group, Inc. (REPL)United States$1.186B-3.13
NOVAVAX INC (NVAX)United States$1.748B-6.26
Vir Biotechnology, Inc. (VIR)United States$1.814B-6.85
Vor Biopharma Inc. (VOR)United States$1.091B1.60
MeiraGTx Holdings plc (MGTX)United States$1.061B16.10
Monte Rosa Therapeutics, Inc. (GLUE)United States$1.002B-12.81